Adverse Event Reporting Hotline Being Refined Through FDA Labeling Study
Executive Summary
FDA is honing in on the wording for the adverse event statement to be included on labeling as part of the agency's proposed rule to add a toll-free number to the MedWatch adverse event reporting system
You may also be interested in...
Side Effects? FDA May Require Adverse Event Hotline Even As Surveys Continue
An adverse event statement may appear on drug product labeling before FDA can determine the best statement to apply
Side Effects? FDA May Require Adverse Event Hotline Even As Surveys Continue
An adverse event statement may appear on drug product labeling before FDA can determine the best statement to apply
PDUFA Draft Bill Adds $70 Mil. For Rx Safety To User Fee Totals; Mark-Up Looms
A draft of the bill to reauthorize FDA's user fee program would add $70 million to the total fee negotiated by the agency and industry in order to pay for additional Rx safety oversight